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SUMMARY 
 
   Aim: to evaluate changes in the treatment trends of the larynx cancer over the last few decades 
concerning the time factor in postoperative radiotherapy (OTT) after total laryngectomy and defining 
the target in adjuvant radiotherapy after partial laryngectomy with the reconstruction of the larynx.  
   Material and methods: The first part of the analysis was based on the comparison of OTT in two 
groups of patients (group A and B) irradiated postoperatively after total laryngectomy. Group A 
consisted of 311 patients who were treated between 1986 and 1990. The postoperative radiotherapy 
(RT) was given 5 times a week at the daily dose of 2 Gy per fraction to the mean total dose of 61.2 Gy 
(range: 57-66 Gy), the mean time of the RT course was 47 days (range: 40-74 days). Group B 
encompassed 270 patients treated with a similar technique in the years 2000-2002 with the same 
fraction and total dose. 
   The second part of the analysis concerning the change of strategy in relation to the indication 
for adjuvant radiotherapy after partial laryngectomy (supracricoid laryngectomy with cricohyoidopexy, 
cricohyoidoepiglottopexy, horizontal laryngectomy, and fronto-lateral laryngectomy) during the last 
decade. The analysis was based on the review of patients who were treated between 1996 and 2002 
at our department. One of the main aims of radiotherapy technique was to avoid the irradiation 
of a newly reconstructed larynx. All patients were irradiated postoperatively in a conventional way to 
the elective dose of 50 Gy to the neck with a boost dose from 10 to 16 Gy to the bed of the removed 
lymph nodes. Acute and late morbidities were evaluated according to the RTOG/EORTC morbidity 
scoring system. 
   Results and conclusion: In group A gaps were observed in 52% of all the treated patients and their 
mean time was 8.2 days (range: 1-16 days). In group B gaps occurred in 26% of all treated patients 
with the mean gaps duration of 4.2 days (range: 1-15 days). The first part of the analysis revealed 
a significant time reduction in gap duration (4.2 days) and their frequency (26%) in the last decade 
(p=0.002).  
The second part of the analysis showed that the protection of the newly reconstructed larynx led to 
the avoidance of significant side effects. Combined treatment, which consisted of partial laryngectomy 
and adjuvant RT of the neck with the protection of larynx, plays an important role in the decrease 
of treatment morbidity and makes it possible to preserve laryngeal function. 
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INTRODUCTION 
 
   Radiotherapy is one of the most im-
portant methods of treatment in laryngeal 
cancer but in more advanced stages of the 
disease it is mainly advocated as a post-
operative method of treatment. The dura-
tion of the radiotherapy course is consi-
dered as one of the clinical factors which 
can significantly result in locoregional con- 
trol (LRC) [1-4], which has been confirmed 
by considerable evidence based on retros-
pective analyses. Generally, it has been 
established that prolongation by one day 
of RT course is connected with a drop 
in LRC in the range from 1% to 2% [2-4]. 
These facts have changed the policy 
of treatment in radiotherapy departments 
related to the time factor.  
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   Routine application of adjuvant RT, 
which encompassed the reconstructed 
larynx for patients after partial laryngecto-
my with the reconstruction of the larynx, 
produces a large number of side effects 
[5-8]. Thus, postoperative radiotherapy is 
reserved to individual patients, only when 
such a treatment may produce benefit. 
In the case of metastases in the neck such 
combined treatment lead to therapeutic 
gain.  
   In this work, we have evaluate the policy 
of treatment over the last decade at our 
department related to the time factor 
(gaps) in adjuvant RT after total larynge-
ctomy and target definition in adjuvant RT 
after partial laryngectomy.  
 
MATERIAL AND METHODS 
 
The time factor (gaps during adjuvant 
radiotherapy) 
   Two groups of patients were distin-
guished on the basis of the following pe-
riods of treatment: group A (311 patients) 
treated between January 1986 and 
December 1990, and group B (270 pa-
tients) treated in the years 2000-2002. 
The charts of all patients selected in this 
analysis were reviewed retrospectively. All 
patients were in stage III or IV (1992 AJCC 
staging system) of the histologically pro-
ven squamous cell carcinoma of the la-
rynx. In each case, a surgery at the De-
partment of Otolaryngology, PoznaĔ Uni-
versity of Medical Sciences and a post-
operative RT at the Department of Radio-
therapy at the Greatpoland Cancer Center 
in PoznaĔ were performed. The conven-
tional postoperative RT was given 5 times 
a week at the daily dose of 2 Gy to the 
mean total dose of 61.2 Gy (range: 57 
-66 Gy) to the tumour bed in the first 
group, and the mean dose of 62,2 Gy 
(range: 58-68 Gy) in the second group. 
In each case, additional lower neck field 
was applied to the total dose of 50 Gy. 
During RT some gaps in both groups 
of patients were observed.  
 
Target in postoperative radiotherapy 
after partial laryngectomy 
   This part of the analysis was based on 
the retrospective review of patients treated 
at our departments. The combined treat-
ment for the patients analyzed consisted 
of partial laryngectomy with selective neck 
dissection and adjuvant RT. The following 
conservative techniques of partial larynge-
ctomy in both groups were carried out: 
supracricoid laryngectomy with crico-
hyoidopexy (CHP), cricohyoidoepiglotto-
pexy (CHEP), horizontal laryngectomy, 
and frontolateral laryngectomy. Homola-
teral or bilateral selective lymph nodes 
dissection was performed in all patients 
suspected of metastases to the lymph 
nodes during ultrasonography exami-
nation. Only patients with good performan-
ce status (Karnofsky scale as 70 or above) 
and under the age of 60 were included in 
this study. The postoperative RT was only 
recommended in the case of pathologically 
confirmed metastases to the neck with 
additional risk factors such as extracap-
sular infiltration, or multiple metastases or 
positive postoperative margin. It is nece-
ssary to add that the neck was the only 
target for RT with additional protection 
of the newly reconstructed larynx. Patients 
were treated with 6 MV X-rays with the 
application of two lateral portals encompa-
ssing selectively all neck lymph nodes. 
The conventional postoperative RT was 
given 5 times a week at the dose of 2 Gy 
per fraction to the median total dose 
of 50 Gy to all the lymph nodes with in-
dividual shielding of the reconstructed 
larynx. During the second phase of RT 
an additional dose (boost) of 16 Gy was 
added to the region of high risk of re-
currence e.g. to the bed of the removed 
metastatic lymph node. It should be em-
phasized that treatment planning was 
based on CT planning in all patients, 
the majority of whom were also given 
three-dimensional conformal radiotherapy 
planning and treatment procedure (3D 
CRT). This procedure provided better 
shielding of the reconstructed larynx.  
   The analyzed group of patients encom-
passed 17 patients who were treated 
between January 1996 and March 2002: 
10 patients underwent homolateral neck 
dissection, and 7 patients bilateral neck 
dissection. The pathological report revea-
led pN1 metastases in 11 cases and pN2 
in 6 cases (metastases were found in the 
regions II and/or III). Patients treated expe-
rienced only some worsening in the quality 
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of voice. The mean time of the fllow-up was 
5 years (range: 1 to 6 years). 
   The follow-up 
   After the completion of adjuvant radio-
therapy, all patients were evaluated for side 
effects (acute and late) according to the Ra-
diation Therapy Oncology Group (EORTC/ 
RTOG) scoring system. During radiothera-
py no gaps were noted because of side 
effects related to RT.  
 
RESULTS 
 
Gaps in adjuvant radiotherapy 
   During RT some gaps in both groups 
were observed because of acute muco-
sitis, concurrent diseases, breakdown 
of the therapeutic machine, problems with 
the transport of patients, and public holi-
days. The mean duration of gaps in group 
A was 8.2 days (range: 1-16 days). In this 
group, gaps were observed in 52% of all 
patients treated. In the second group 
(group B) the mean duration of gaps was 
4.2 days (range: 1-15 days), and the rate 
of gaps in radiotherapy was 26% of all 
patients irradiated. The statistical analysis 
(test Mc Nemary) revealed that this obser-
vation is statistically significant (p= 0.002).  
 
Target in partial laryngectomy 
   The crude 3-year overall survival rate 
was 17/17, and the LRC rate for the entire 
group was 1/17. All patients completed 
the entire course of radiotherapy without 
any gaps. No significant acute and late 
side effects (oedema, dyspnoe, dysphagia 
or pain) were observed. Toxicity concer-
ning the skin and mucosa of the pharynx 
grade 1 or 2 according the RTOG/EORTC 
classification was observed. No acute and 
late side effects grade 2 and 3 were obser-
ved. 
  
DISCUSSION 
 
   In advanced laryngeal cancer, combined 
treatment consisting of surgery and post-
operative radiotherapy is a standard treat-
ment in many centres across the world 
[9,10]. Despite the fact that the margins 
of resection are described as negative, 
postoperative radiotherapy in head and 
neck cancer is usually recommended due 
to the significant relapse rate in T3 or T4 
tumors and pN1 or pN2 or pN3 neck 
disease [9, 10].  
   In 1988, Withers and co-workers [11] 
indicated that the prolongation of the ra-
diotherapy treatment time in head and 
neck cancer had very negative effect on 
locoregional control of the disease. 
Numerous retrospective data from lite-
rature showed that the protraction of RT 
alone or postoperative RT caused a sub-
stantial drop in the LC of disease [1-3]. 
The accelerated repopulation of clonoge-
nic tumour cells is responsible for such 
negative effect of the time factor [4]. This 
fact has been known since the 1990s, but 
it is also known that the introduction 
of a new standard of treatment in routine 
clinical practice based on the results of cli-
nical trials takes some time, which may 
widely differ from institution to institution. 
The reasons for the later introduction 
of the new standard of treatment are: 
organizational problems, previous expe-
rience, anxiety about the side effects, old 
habits etc. During the last decade at our 
department the mean time of gaps redu-
ction during treatment time was 4.2 days, 
but there still exists a place for impro-
vement. In the years 1986-1990 the occu-
rrence of gaps during the course of posto-
perative RT was 52%, but in the years 
2000/02 it dropped to 26%. Unexpectedly, 
in the last few years, some gaps were 
caused mainly by holidays and acute mor-
bidity. The latest changes in the organi-
zation of our department related have 
provided some possibility of additional irra-
diation on Saturdays when some breaks 
occurred during irradiation caused by holi-
days or breakdown of therapeutic machi-
nes. This made it possible to reduce 
the treatment time and eliminate the effect 
of unexpected gaps in the course of RT. 
In addition, it have been reduced the gaps 
caused by acute side effects by introdu-
cing more intensive supportive treatment 
of patients during irradiation.   
   Another issue, which addressed in this 
paper, involves the definition of a target 
for adjuvant RT in partial laryngectomy 
with the reconstruction of the larynx. 
Developments in microsurgery of laryngeal 
cancer allow introducing this method 
of treatment in routine clinical practice. 
These surgical techniques are alternatives 
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to total laryngectomy and/or curative radio-
therapy [12,13]. The most popular techni-
ques of conservative surgery are supra-
cricoid laryngectomy with the recon-
struction of the larynx (cricohyoidopexy 
and cricohyoidoepiglottopexy), supraglottic 
laryngectomy, and horizontal larynge-
ctomy [14]. These techniques make it po-
ssible to preserve voice function with 
the natural passage of air during the breat-
hing process and at the same time give 
the possibility for an adequate removing 
of the tumour. 
   Our analysis has shown that adjuvant 
radiotherapy of the neck after conservative 
surgery of the larynx with selective neck 
dissection with metastases to the neck 
was associated with excellent LC without 
any clinically significant acute and late 
morbidity of the operated on larynx. These 
results were possible since the irradiation 
was focused on the neck with the prote-
ction of the larynx. After surgery in the ca-
se of metastases to the neck the amount 
of cancer cells may differ over a broad 
spectrum and in some patients no cancer 
cells can be expected (no RT is needed). 
On the other hand, the network of lymph 
nodes of the neck (a microscopic disease) 
may contain 109 of cancer cells. For this 
reason, one of the most important indica-
tion for adjuvant radiotherapy of the neck 
in patients with head and neck cancer are 
metastases, especially those with extra-
capsular infiltration.  
   Another factor, which should be taken 
into account, is the fact that accelerated 
repopulation of clonogenic cells is pro-
bably limited mainly to surgery fields 
(the area of lymph nodes dissection) and 
for this reason the implementation of ra-
diotherapy with additional dose (boost) 
to the scar may positively effect the results 
of combined treatment. In our material, 
the high risk of subclinical involvement 
of lymph nodes in the neck was the indi-
cation for the adjuvant radiotherapy. We 
could not perform any statistical analysis 
with patients who were irradiated on the 
entire new reconstructed larynx because 
before 1996 the postoperative irradiation 
in case of partial laryngectomy was not 
performed.  
   The primary aim of the treatment in la-
rynx cancer is cure, but also another as-
pect of the treatment should be considered 
in each case. This is the patient’s quality 
of life after the completion of the treat-
ment. In general, it can be said that 
treatment is a specific kind of “game” or 
“battle” between the killings of cancer cells 
and protecting the healthy ones. What is 
especially important for patients with the 
larynx cancer is to have the function of this 
organ preserved. Thus, function presser-
ving treatment should be considered 
in neach and every patient. Generally, we 
can choose between surgery and primary 
radiotherapy. Thus, only one method of treat-
ment should be carred out and the combi-
nation of both procedures is unreasonable 
due to increased economical costs and 
higher morbidity. Generally, numerous 
data from the literature indicate that 
the chances of local control in radiothe-
rapy alone decrease significantly with 
the increase in the tumour volume, which 
is to be expected for larger of T2 or T3 
tumours [10]. Thus, at our department sur-
gery is the preferred policy of treatment, 
but in the cases when, after partial laryn-
gectomy, the pathological examination 
after selective neck dissection revealed 
metastases to the neck the question arose 
as to the application of adjuvant radiothe-
rapy. The simplest answer is to advocate 
the application of postoperative radiothe-
rapy. On the other hand, numerous retros-
pective data indicate that the irradiation 
of a newly reconstructed larynx is contro-
versial due to the high risk of late toxicity 
concerned the larynx. Laccourreye et al. 
[8] from their retrospective study of 90 
patients established that severe compli-
cations after combined treatment occurred 
in 15 patients. Severe complications, 
which led to the death of 3 patients (3.3%), 
permanent gastrostomy in 3 (3.3%), and 
permanent tracheostomy one patient 
(1.1%). These authors have reported that 
the mean dose delivered to the larynx was 
the only variable statistically related to the 
incidence of severe complications. 
   In another study, conducted by Spriano 
et al. [15], postoperative radiotherapy was 
added for presumed microscopic disease 
at the primary site (the larynx), regional 
nodes, or both. The 2- and 5-year actuarial 
locoregional control values were 85% and 
83%, respectively. Thirty patients (54%) 
Rep. Pract. Oncol. Radiother. 9 (1) 2004 
Milecki et al.: Adjuvant radiotherapy … 
 
developed laryngeal complications. Howe-
ver, only one patient experienced grade 
4 laryngeal oedema requiring permanent 
tracheostomy. At multivariate analysis, 
the treated volume (p=0.03) and, the total 
dose to the larynx (p=0.03) were signi-
ficantly associated with a high level of lo-
cal toxicity. In the conclusion the authors 
stated that after partial laryngectomy, 
postoperative radiotherapy to the neck did 
not affect local morbidity when careful 
radiotherapy planning was implemented 
to avoid the irradiation of the larynx.  
   A similar treatment strategy to ours was 
presented by Wang et al. [16] as these 
authors applied radiotherapy only to the 
neck. This made it possible to preserve 
the vocal and swallowing function without 
serious complications. It is worthy under-
lining that radiotherapy was added in the 
case of positive margins, vascular inva-
sion, and extranodal spread of disease. 
Similar indications for adjuvant radiothe-
rapy were applied in our group of patients. 
Finally, the authors stated that they did not 
observe any major problems involving 
postoperative wound healing or airway 
management during radiation treatment. 
Gregor et al [6] on the basis of their on his 
analysis of 89 patients who underwent 
partial laryngectomy combined with post-
operative radiotherapy of the neck postu-
lated that no additional toxicity from the 
larynx could be expected when radio-
therapy was applied only to the neck. Also 
Lutz et co-workers [8] showed that post-
operative radiotherapy improved the re-
sults of treatment. According to these in-
vestigators, in the group of patients wit-
hout irradiation of the neck the 23% 
regional recurrences were observed. 
On the other hand, the introduction of ad-
juvant radiotherapy allowed to the decree-
ase the risk of local failure to 8%. 
   It is obvious that postoperative radiothe-
rapy in patients without any significant risk 
factors for regional recurrence should be 
also ruled out and such a strategy of treat-
ment was introduced in our departments. 
   Generally, for all head and neck cancers 
in the case of pathologically proved meta-
stases (pN1 with extracapsular infiltration, 
pN2) to the lymph nodes adjuvant radio-
therapy is advocated [17]. On the other 
hand, the application of postoperative 
radiotherapy in patients after partial laryn-
gectomies with the reconstruction of the 
larynx led to the increase in acute and late 
side effects in the larynx. Therefore, such 
a combined strategy may cause some 
controversies due to the negative effect 
of irradiation on the physiological function 
of the newly reconstructed larynx [6,18]. 
Oedema of mucosa and cartilage may 
even lead to the necrosis and the need 
for permanent tracheostomy [8]. Changes 
that led to the protection of the new re-
constructed larynx allowed us to avoid 
some serious complications of treatment. 
The efficancy of radiotherapy did not 
change but the toxicity was reduced. It is 
worth adding that such combined treat-
ment is only indicated in individual cases 
[19]. 
 
CONCLUSIONS 
 
   In the last decade, at our department 
the gap in postoperative radiotherapy in la-
ryngeal cancer dropped from 8.2 to 4.2 
days and the percentage of gaps dropped 
from 52% to 26%. 
   By focusing irradiation only to the neck, 
with the protection of the newly reconstru-
cted larynx, which is assumed to be an 
organ at risk apart from the spinal cord, 
made it possible to introduce this type 
of irradiation with minimum side effects 
in patients after partial laryngectomy with 
reconstruction in the case of pN1 with 
extracapsular infiltration and pN2 meta-
stases. 
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